No recent analyst price targets found for NDTP.
Latest News for NDTP
NDT Pharmaceuticals, Inc.'s Wholly Owned Subsidiary Good Salt Life, Inc. Reports Strong Online Retail Growth in First Half of 2026
ATHENS, Ga., July 15, 2026 (GLOBE NEWSWIRE) -- NDT Pharmaceuticals, Inc. (OTC: NDTP) announces that its wholly owned subsidiary Good Salt Life, Inc. (“GSL” or the “Company”) achieved significant growth across its online retail channels during the first half of 2026, with second-quarter sales increasing approximately 50% compared to the first quarter of the year.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NDTP.
U.S. House Trading
No House trades found for NDTP.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.